Korea's Hyundai Introduces Emergency Contraceptive ellaOne To Asia With No Additional Post-marketing Requirements
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Hyundai Pharm. Co. has launched HRA Pharma's oral emergency contraceptive ellaOne (ulipristal acetate) in South Korea, after Korea FDA granted the drug its first market approval in Asia